26 related articles for article (PubMed ID: 23129380)
1. Neoadjuvant Gastric Score: How Response to Neoadjuvant Chemotherapy Affects Overall Survival and Adjuvant Benefit.
Wehrle CJ; Seavey CN; Chang J; Stackhouse K; Woo K; Augustin T; Joyce D; Simon R; Walsh RM; Naffouje SA
Ann Surg Oncol; 2023 Nov; 30(12):7240-7250. PubMed ID: 37659978
[TBL] [Abstract][Full Text] [Related]
2. Imaging advances in efficacy assessment of gastric cancer neoadjuvant chemotherapy.
Deng J; Zhang W; Xu M; Zhou J
Abdom Radiol (NY); 2023 Dec; 48(12):3661-3676. PubMed ID: 37787962
[TBL] [Abstract][Full Text] [Related]
3. A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer.
Wang K; Li E; Busuttil RA; Kong JC; Pattison S; Sung JJY; Yu J; El-Omar EM; Simpson JA; Boussioutas A
Ther Adv Med Oncol; 2020; 12():1758835920930359. PubMed ID: 32754227
[TBL] [Abstract][Full Text] [Related]
4. Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer.
Hu SB; Liu CH; Wang X; Dong YW; Zhao L; Liu HF; Cao Y; Zhong DR; Liu W; Li YL; Gao WS; Bai CM; Shang ZH; Li XY
World J Surg Oncol; 2019 Jan; 17(1):3. PubMed ID: 30606195
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.
Wang J; Qu J; Li Z; Che X; Liu J; Teng Y; Jin B; Zhao M; Liu Y; Qu X
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28238215
[TBL] [Abstract][Full Text] [Related]
6. Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Zhou J; Shen J; Seifer BJ; Jiang S; Wang J; Xiong H; Xie L; Wang L; Sui X
Oncotarget; 2017 May; 8(18):30477-30494. PubMed ID: 27802185
[TBL] [Abstract][Full Text] [Related]
7. Predicting survival in locally advanced gastric cancer using prognostic factors - neoadjuvant rectal score and downstaging depth score.
Tamam S; Culcu S; Erözkan K; Benk MŞ; Azılı C; Altınsoy E; Ersöz Ş; Unal AE
S Afr J Surg; 2024 Mar; 62(1):72-79. PubMed ID: 38568130
[TBL] [Abstract][Full Text] [Related]
8. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
9. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
[TBL] [Abstract][Full Text] [Related]
10. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
11. Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery.
Becker K; Reim D; Novotny A; Zum Büschenfelde CM; Engel J; Friess H; Höfler H; Langer R
Ann Surg; 2012 Dec; 256(6):1002-7. PubMed ID: 22968067
[TBL] [Abstract][Full Text] [Related]
12. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
[TBL] [Abstract][Full Text] [Related]
13. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Sylvie L; Susanne B; Katja O
Recent Results Cancer Res; 2012; 196():269-89. PubMed ID: 23129380
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]